Skip to main content

Peer Review reports

From: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Original Submission
12 May 2020 Submitted Original manuscript
12 May 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
15 May 2020 Editorially accepted
8 Jun 2020 Article published 10.1186/s13063-020-04422-y

You can find further information about peer review here.

Back to article page